{"transactions":[{"id":689927,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-08-12T20:14:48.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vested in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001681643-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000006/edgardoc.xml","form_type":"4"}},{"id":689926,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:14:48.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":800,"price":800,"value":640000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":1703,"source":{"system":"sec-edgar","filing":"0001681643-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000006/edgardoc.xml","form_type":"4"}},{"id":689925,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T20:14:48.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":800,"price":376.69,"value":301352.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":2503,"source":{"system":"sec-edgar","filing":"0001681643-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000006/edgardoc.xml","form_type":"4"}},{"id":889170,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":false,"shares":1638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The stock option vested in three equal annual installments, commencing one year after the date of grant."}],"balance_after":800,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1638},"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889169,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":4,"price":790,"value":3160.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":1703,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889168,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":56,"price":785.61,"value":43994.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents volume-weighted average price of sales of 56 shares of Company stock on February 19, 2026 at prices ranging from $785.60 to $785.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":1707,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889167,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":160,"price":784.45,"value":125512.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 160 shares of Company stock on February 19, 2026 at prices ranging from $784.14 to $784.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":1763,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889166,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":220,"price":783.29,"value":172323.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 220 shares of Company stock on February 19, 2026 at prices ranging from $783.00 to $783.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":1923,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889165,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":298,"price":782.1,"value":233065.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 298 shares of Company stock on February 19, 2026 at prices ranging from $782.01 to $782.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":2143,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889164,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":209,"price":781.28,"value":163287.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 209 shares of Company stock on February 19, 2026 at prices ranging from $781.10 to $781.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":2441,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889163,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":331,"price":780.45,"value":258328.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 331 shares of Company stock on February 19, 2026 at prices ranging from $780.06 to $780.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":2650,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889162,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":208,"price":779.55,"value":162146.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 208 shares of Company stock on February 19, 2026 at prices ranging from $779.10 to $779.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":2981,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889161,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":53,"price":778.47,"value":41258.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 53 shares of Company stock on February 19, 2026 at prices ranging from $778.46 to $778.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 19, 2026 at each separate price."}],"balance_after":3189,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889160,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":50,"price":775.5,"value":38775.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":3242,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889159,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"sale","planned":true,"acquired":false,"shares":49,"price":774.68,"value":37959.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":3292,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":889158,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-23T21:55:58.000Z","date":"2026-02-19","kind":"exercise","planned":true,"acquired":true,"shares":1638,"price":376.69,"value":617018.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 20, 2025."}],"balance_after":3341,"source":{"system":"sec-edgar","filing":"0001681643-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000004/edgardoc.xml","form_type":"4"}},{"id":948763,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-01-06T21:21:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":1962,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1962,"derivative":{"exercise_price":772.76,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":1962},"source":{"system":"sec-edgar","filing":"0001681643-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000002/edgardoc.xml","form_type":"4"}},{"id":948762,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T21:21:24.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1703,"source":{"system":"sec-edgar","filing":"0001681643-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000168164326000002/edgardoc.xml","form_type":"4"}},{"id":1312117,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-01-06T21:11:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1958,"derivative":{"exercise_price":719.37,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":1958},"source":{"system":"sec-edgar","filing":"0001968202-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000009/edgardoc.xml","form_type":"4"}},{"id":1312116,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T21:11:47.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1548,"source":{"system":"sec-edgar","filing":"0001968202-25-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820225000009/edgardoc.xml","form_type":"4"}},{"id":1689464,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:11:18.000Z","date":"2024-01-02","kind":"grant","planned":true,"acquired":true,"shares":1607,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1607,"derivative":{"exercise_price":888.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":1607},"source":{"system":"sec-edgar","filing":"0001968202-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000028/edgardoc.xml","form_type":"4"}},{"id":1689463,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-01-04T21:11:18.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":false,"shares":1117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":1117},"source":{"system":"sec-edgar","filing":"0001968202-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000028/edgardoc.xml","form_type":"4"}},{"id":1689462,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:11:18.000Z","date":"2024-01-02","kind":"grant","planned":true,"acquired":true,"shares":135,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1382,"source":{"system":"sec-edgar","filing":"0001968202-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000028/edgardoc.xml","form_type":"4"}},{"id":1689461,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:11:18.000Z","date":"2024-01-02","kind":"sale","planned":true,"acquired":false,"shares":1117,"price":900,"value":1005300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001968202-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000028/edgardoc.xml","form_type":"4"}},{"id":1689460,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-04T21:11:18.000Z","date":"2024-01-02","kind":"exercise","planned":true,"acquired":true,"shares":1117,"price":391.92,"value":437774.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."}],"balance_after":2364,"source":{"system":"sec-edgar","filing":"0001968202-24-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820224000028/edgardoc.xml","form_type":"4"}},{"id":1759346,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-10-17T20:06:37.000Z","date":"2023-10-13","kind":"exercise","planned":true,"acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":1117,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001968202-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000037/edgardoc.xml","form_type":"4"}},{"id":1759345,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-17T20:06:37.000Z","date":"2023-10-13","kind":"sale","planned":true,"acquired":false,"shares":1000,"price":850,"value":850000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001968202-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000037/edgardoc.xml","form_type":"4"}},{"id":1759344,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-17T20:06:37.000Z","date":"2023-10-13","kind":"exercise","planned":true,"acquired":true,"shares":1000,"price":391.92,"value":391920.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on May 5, 2023."}],"balance_after":2247,"source":{"system":"sec-edgar","filing":"0001968202-23-000037","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000196820223000037/edgardoc.xml","form_type":"4"}},{"id":2064233,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T21:15:36.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":1929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":1929,"derivative":{"exercise_price":725.89,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":1929},"source":{"system":"sec-edgar","filing":"0001883850-23-000013","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000013/edgardoc.xml","form_type":"4"}},{"id":2064232,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-05T21:15:36.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":165,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1247,"source":{"system":"sec-edgar","filing":"0001883850-23-000013","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385023000013/edgardoc.xml","form_type":"4"}},{"id":2325509,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-03-18T20:14:46.000Z","date":"2022-03-16","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2117,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001708138-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000024/edgardoc.xml","form_type":"4"}},{"id":2325508,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-18T20:14:46.000Z","date":"2022-03-16","kind":"sale","acquired":false,"shares":2000,"price":675,"value":1350000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001708138-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000024/edgardoc.xml","form_type":"4"}},{"id":2325507,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-18T20:14:46.000Z","date":"2022-03-16","kind":"exercise","acquired":true,"shares":2000,"price":391.92,"value":783840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":3082,"source":{"system":"sec-edgar","filing":"0001708138-22-000024","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813822000024/edgardoc.xml","form_type":"4"}},{"id":2445910,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-01-05T21:24:18.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":2707,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":2707,"derivative":{"exercise_price":625.6,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":2707},"source":{"system":"sec-edgar","filing":"0001883850-22-000009","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000009/edgardoc.xml","form_type":"4"}},{"id":2445909,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-05T21:24:18.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1082,"source":{"system":"sec-edgar","filing":"0001883850-22-000009","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000188385022000009/edgardoc.xml","form_type":"4"}},{"id":2570089,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-14","kind":"exercise","acquired":false,"shares":998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":4117,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":998},"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2570088,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-13","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":5115,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2570087,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-14","kind":"sale","acquired":false,"shares":998,"price":650,"value":648700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2570086,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-14","kind":"exercise","acquired":true,"shares":998,"price":391.92,"value":391136.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":1889,"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2570085,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":2,"price":651.1,"value":1302.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2570084,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-15T20:03:12.000Z","date":"2021-09-13","kind":"exercise","acquired":true,"shares":2,"price":391.92,"value":783.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":893,"source":{"system":"sec-edgar","filing":"0001708138-21-000081","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000081/edgardoc.xml","form_type":"4"}},{"id":2923394,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-01-05T21:11:56.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":3613,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3613,"derivative":{"exercise_price":482.68,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":3613},"source":{"system":"sec-edgar","filing":"0001708138-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000010/edgardoc.xml","form_type":"4"}},{"id":2923393,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T21:11:56.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":248,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":891,"source":{"system":"sec-edgar","filing":"0001708138-21-000010","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813821000010/edgardoc.xml","form_type":"4"}},{"id":3087020,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-08T20:14:40.000Z","date":"2020-07-07","kind":"exercise","acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":5117,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001237899-20-000028","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000028/edgardoc.xml","form_type":"4"}},{"id":3087019,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-08T20:14:40.000Z","date":"2020-07-07","kind":"sale","acquired":false,"shares":1706,"price":650,"value":1108900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":643,"source":{"system":"sec-edgar","filing":"0001237899-20-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000028/edgardoc.xml","form_type":"4"}},{"id":3087018,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-08T20:14:40.000Z","date":"2020-07-07","kind":"exercise","acquired":true,"shares":1706,"price":391.92,"value":668615.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2349,"source":{"system":"sec-edgar","filing":"0001237899-20-000028","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789920000028/edgardoc.xml","form_type":"4"}},{"id":3112493,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-11","kind":"exercise","acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":6823,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112492,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"exercise","acquired":false,"shares":1706,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":8529,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":1706},"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112491,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-11","kind":"sale","acquired":false,"shares":1706,"price":625,"value":1066250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":643,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112490,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-11","kind":"exercise","acquired":true,"shares":1706,"price":391.92,"value":668615.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2349,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112489,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":99,"price":616.19,"value":61002.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":643,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112488,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":80,"price":615.28,"value":49222.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":742,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112487,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":5,"price":613.03,"value":3065.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":822,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112486,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":265,"price":612.52,"value":162317.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Represents volume-weighted average price of sales of 265 shares of Company stock on June 10, 2020 at prices ranging from $612.12 to $612.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":827,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112485,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":164,"price":611.46,"value":100279.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Represents volume-weighted average price of sales of 164 shares of Company stock on June 10, 2020 at prices ranging from $611.06 to $611.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":1092,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112484,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":202,"price":610.41,"value":123302.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Represents volume-weighted average price of sales of 202 shares of Company stock on June 10, 2020 at prices ranging from $610.18 to $610.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":1256,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112483,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":161,"price":609.48,"value":98126.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents volume-weighted average price of sales of 161 shares of Company stock on June 10, 2020 at prices ranging from $609.31 to $609.85. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":1458,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112482,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":330,"price":608.62,"value":200844.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 330 shares of Company stock on June 10, 2020 at prices ranging from $608.15 to $608.9. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":1619,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112481,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":251,"price":607.64,"value":152517.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 251 shares of Company stock on June 10, 2020 at prices ranging from $607.02 to $607.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":1949,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112480,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"sale","acquired":false,"shares":149,"price":606.64,"value":90389.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 149 shares of Company stock on June 10, 2020 at prices ranging from $606.23 to $606.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 10, 2020 at each separate price."}],"balance_after":2200,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3112479,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T20:03:10.000Z","date":"2020-06-10","kind":"exercise","acquired":true,"shares":1706,"price":391.92,"value":668615.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c)."}],"balance_after":2349,"source":{"system":"sec-edgar","filing":"0001708138-20-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000072/edgardoc.xml","form_type":"4"}},{"id":3157255,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"exercise","acquired":false,"shares":5118,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":10235,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":5118},"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157254,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":13,"price":569.2,"value":7399.6,"ownership":{"direct":true},"balance_after":643,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157253,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":609,"price":568.37,"value":346137.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents volume-weighted average price of sales of 609 shares of Company stock on May 7, 2020 at prices ranging from $568.05 to $568.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price."}],"balance_after":656,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157252,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":646,"price":567.58,"value":366656.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents volume-weighted average price of sales of 646 shares of Company stock on May 7, 2020 at prices ranging from $567.20 to $567.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price."}],"balance_after":1265,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157251,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":2128,"price":566.37,"value":1205235.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents volume-weighted average price of sales of 2,128 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price."}],"balance_after":1911,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157250,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"sale","acquired":false,"shares":1722,"price":565.64,"value":974032.08,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents volume-weighted average price of sales of 1,722 shares of Company stock on May 7, 2020 at prices ranging from $565.43 to $565.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price."}],"balance_after":4039,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3157249,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-08T20:03:06.000Z","date":"2020-05-07","kind":"exercise","acquired":true,"shares":5118,"price":391.92,"value":2005846.56,"ownership":{"direct":true},"balance_after":5761,"source":{"system":"sec-edgar","filing":"0001708138-20-000050","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000050/edgardoc.xml","form_type":"4"}},{"id":3320061,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-01-06T21:04:18.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":4361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":4361,"derivative":{"exercise_price":374.12,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":4361},"source":{"system":"sec-edgar","filing":"0001708138-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000006/edgardoc.xml","form_type":"4"}},{"id":3320060,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T21:04:18.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":320,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":643,"source":{"system":"sec-edgar","filing":"0001708138-20-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813820000006/edgardoc.xml","form_type":"4"}},{"id":3706109,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-01-04T21:05:49.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":3784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that has passed from the date of grant shall then become exercisable, and the remainder shall become exercisable on the first anniversary of the date of grant."}],"balance_after":3784,"derivative":{"exercise_price":371.4,"expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":3784},"source":{"system":"sec-edgar","filing":"0001708138-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813819000006/edgardoc.xml","form_type":"4"}},{"id":3706108,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:05:49.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects an acquisition of time-based vesting restricted stock units each representing a contingent right to receive one share of the Issuer's common stock."}],"balance_after":323,"source":{"system":"sec-edgar","filing":"0001708138-19-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813819000006/edgardoc.xml","form_type":"4"}},{"id":4114755,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-01-03T21:14:10.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":7439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":7439,"derivative":{"exercise_price":380.95,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":7439},"source":{"system":"sec-edgar","filing":"0001708138-18-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000170813818000004/edgardoc.xml","form_type":"4"}},{"id":4505056,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-01-04T21:10:19.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":2438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":2438,"derivative":{"exercise_price":376.69,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":2438},"source":{"system":"sec-edgar","filing":"0001237899-17-000001","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000123789917000001/edgardoc.xml","form_type":"4"}},{"id":4606093,"issuer":{"id":2010,"kind":"organization","name":"REGENERON PHARMACEUTICALS, INC.","symbol":"REGN"},"owners":[{"id":24351,"kind":"person","name":"Zoghbi Huda Y","position":1,"cik":"0001681643","reported_name":"Zoghbi Huda Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2016-09-12T20:25:43.000Z","date":"2016-09-09","kind":"grant","acquired":true,"shares":15353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant."}],"balance_after":15353,"derivative":{"exercise_price":391.92,"expiration_date":"2026-09-09","underlying":"Common Stock","underlying_shares":15353},"source":{"system":"sec-edgar","filing":"0001104659-16-144227","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/872589/000110465916144227/a4.xml","form_type":"4"}}]}